18mon MSN
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and pharmaceutical imports, and raise it substantially over the course of a year, a move ...
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...
The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy’s dropped as much as 4%, and ...
An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S.
Dr. Reddys Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest ...
Sun Pharma and Dr Reddy’s Lab were among the key index losers that led to the Nifty slipping in early trade.Other pharma ...
Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...
Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
Sun Pharmaceutical Industries Ltd. closed 13.20% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results